Rbin-2

CAS No. 2032282-97-4

Rbin-2( —— )

Catalog No. M34391 CAS No. 2032282-97-4

Rbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 Get Quote
5MG 85 Get Quote
10MG 147 Get Quote
25MG 319 Get Quote
50MG 511 Get Quote
100MG 731 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rbin-2
  • Note
    Research use only, not for human use.
  • Brief Description
    Rbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).
  • Description
    Rbin-2 is a potent, reversible and selective inhibitor of Midasin (Mdn1), an enzyme belonging to the AAA+ (ATPases associated with diverse cellular activities) protein family. Rbin-2 inhibits eukaryotic ribosome biogenesis and is a powerfulprobe for the eukaryotic ribosome assembly.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2032282-97-4
  • Formula Weight
    335.22
  • Molecular Formula
    C13H11BrN4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 8.33 mg/mL (24.85 mM; Ultrasonic (<60°C)
  • SMILES
    S(CC(C)=C)C=1N=C2C(C=3C(N2)=CC(Br)=CC3)=NN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kawashima SA, et al. Potent, Reversible, and Specific Chemical Inhibitors of Eukaryotic Ribosome Biogenesis. Cell. 2016 Oct 6;167(2):512-524.e14. ?
molnova catalog
related products
  • PTP Inhibitor IV

    PTP Inhibitor IV is an effective protein tyrosine phosphatase (PTP) inhibitor, which can selectively inhibit DUSP14 phosphatase activity (IC50.5.21μm).

  • LFHP-1c

    LFHP-1c is a novel PGAM5 inhibitor that shows neuroprotective activity in an ischemic stroke model, preventing BBB destruction after transient middle cerebral artery occlusion (tMCAO) in rats.LFHP-1c can be used to study cerebral ischemic stroke.

  • Tegeprotafib

    Tegeprotafib (PTPN2/1-IN-1, Compound 124) is an orally active inhibitor targeting both PTPN2 and PTPN1B, with potent IC50 values of 4.4 nM for PTPN2 and 1-10 nM for PTPN1B, respectively .